Market Overview

Boston Scientific Corporation Sees Q1 Sales $1.74B-1.82B vs $1.79B Est, Sees FY13 Sales $7.05B-7.35B vs $7.12B Est.

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance

 

Most Popular

Related Articles (BSX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free